Home > Publications Database > Reduced tear fluid production in neurological diseases: a cohort study in 708 patients. > print

001     268773
005     20240409115716.0
024 7 _ |a pmc:PMC10973005
|2 pmc
024 7 _ |a 10.1007/s00415-023-12104-3
|2 doi
024 7 _ |a pmid:38063868
|2 pmid
024 7 _ |a 0367-004X
|2 ISSN
024 7 _ |a 0012-1037
|2 ISSN
024 7 _ |a 0340-5354
|2 ISSN
024 7 _ |a 1432-1459
|2 ISSN
037 _ _ |a DZNE-2024-00317
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Luib, Elena
|b 0
245 _ _ |a Reduced tear fluid production in neurological diseases: a cohort study in 708 patients.
260 _ _ |a Heidelberg
|c 2024
|b Springer
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1712654682_12205
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Tear fluid (TF) production is an important component of normal ocular function. It is regulated by parasympathetic and sympathetic innervation. Because parasympathetic nerve fibers originate in the brainstem, pathology in this brain region may affect TF production. For example, a reduction in TF production has been described in patients with Parkinson's disease (PD).TF was collected at one center from 772 individuals, 708 of which were patients with different neurological diseases, and 64 healthy controls. Wetting lengths (WL) were recorded using Schirmer test strips with a collection time of 10 min.WL correlated negatively with age and was significantly reduced in subgroups of patients with neurodegenerative diseases (NDDs) (PD, Amyotrophic lateral sclerosis (ALS), other motor neuron diseases (MNDs)), as well as inflammatory/autoimmune/infectious central nervous system (CNS) diseases and vascular CNS diseases (VCDs), even if corrected for age or sex. While temperature had a significant negative effect on TF production, other environmental factors, such as hours of sunlight and humidity, did not.WL was altered in many neurological diseases compared to healthy controls. Most importantly, we observed a reduction of WL in NDDs, independent of age or sex. This study highlights the potential of WL as an easily obtainable parameter and suggests functional alterations in the autonomic innervation in various neurological disorders.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a Neurodegeneration
|2 Other
650 _ 7 |a Neurological diseases
|2 Other
650 _ 7 |a Tear fluid
|2 Other
650 _ 7 |a Wetting length
|2 Other
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Cohort Studies
|2 MeSH
650 _ 2 |a Nervous System Diseases
|2 MeSH
650 _ 2 |a Motor Neuron Disease
|2 MeSH
650 _ 2 |a Amyotrophic Lateral Sclerosis: pathology
|2 MeSH
650 _ 2 |a Brain: pathology
|2 MeSH
650 _ 2 |a Parkinson Disease
|2 MeSH
700 1 _ |a Demleitner, Antonia F
|b 1
700 1 _ |a Cordts, Isabell
|b 2
700 1 _ |a Westenberg, Erica
|b 3
700 1 _ |a Rau, Petra
|b 4
700 1 _ |a Pürner, Dominik
|b 5
700 1 _ |a Haller, Bernhard
|b 6
700 1 _ |a Lingor, Paul
|0 P:(DE-2719)2812561
|b 7
|e Last author
773 _ _ |a 10.1007/s00415-023-12104-3
|g Vol. 271, no. 4, p. 1824 - 1836
|0 PERI:(DE-600)1421299-7
|n 4
|p 1824 - 1836
|t Journal of neurology
|v 271
|y 2024
|x 0367-004X
856 4 _ |u https://pub.dzne.de/record/268773/files/DZNE-2024-00317%20SUP1.xlsx
856 4 _ |u https://pub.dzne.de/record/268773/files/DZNE-2024-00317%20SUP3.docx
856 4 _ |u https://pub.dzne.de/record/268773/files/DZNE-2024-00317%20SUP4.xlsx
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/268773/files/DZNE-2024-00317.pdf
856 4 _ |u https://pub.dzne.de/record/268773/files/DZNE-2024-00317%20SUP1.csv
856 4 _ |u https://pub.dzne.de/record/268773/files/DZNE-2024-00317%20SUP1.ods
856 4 _ |u https://pub.dzne.de/record/268773/files/DZNE-2024-00317%20SUP1.xls
856 4 _ |u https://pub.dzne.de/record/268773/files/DZNE-2024-00317%20SUP3.doc
856 4 _ |u https://pub.dzne.de/record/268773/files/DZNE-2024-00317%20SUP3.odt
856 4 _ |u https://pub.dzne.de/record/268773/files/DZNE-2024-00317%20SUP3.pdf
856 4 _ |u https://pub.dzne.de/record/268773/files/DZNE-2024-00317%20SUP4.csv
856 4 _ |u https://pub.dzne.de/record/268773/files/DZNE-2024-00317%20SUP4.ods
856 4 _ |u https://pub.dzne.de/record/268773/files/DZNE-2024-00317%20SUP4.xls
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/268773/files/DZNE-2024-00317.pdf?subformat=pdfa
909 C O |o oai:pub.dzne.de:268773
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 7
|6 P:(DE-2719)2812561
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2024
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-10-21
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J NEUROL : 2022
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-10-21
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-10-21
915 _ _ |a DEAL Springer
|0 StatID:(DE-HGF)3002
|2 StatID
|d 2023-10-21
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-21
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2023-10-21
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b J NEUROL : 2022
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-21
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2023-10-21
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-21
920 1 _ |0 I:(DE-2719)1111015
|k Clinical Research (Munich)
|l Clinical Research (Munich)
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1111015
980 1 _ |a FullTexts

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21